Page last updated: 2024-08-17

levodopa and Hemorrhagic Fevers, Viral

levodopa has been researched along with Hemorrhagic Fevers, Viral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fukasawa, M; Gemba, R; Irie, T; Murae, M; Noguchi, K; Ogawa, M; Saijo, M; Shimojima, M	1

Other Studies

1 other study(ies) available for levodopa and Hemorrhagic Fevers, Viral

Article	Year
L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:3 Topics: Bunyaviridae Infections; Hemorrhagic Fevers, Viral; Humans; Levodopa; Parkinson Disease; Phlebovirus; Severe Fever with Thrombocytopenia Syndrome; Thrombocytopenia	2022

Article

Year

L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:3

Topics: Bunyaviridae Infections; Hemorrhagic Fevers, Viral; Humans; Levodopa; Parkinson Disease; Phlebovirus; Severe Fever with Thrombocytopenia Syndrome; Thrombocytopenia

2022